Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
India flag India · Delayed Price · Currency is INR
68.00
0.00 (0.00%)
At close: Jul 30, 2026

NSE:AAKAAR Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
592.04615.83461.11327.85194.65124.38
Revenue Growth
-33.55%40.65%68.42%56.50%-45.88%
Gross Profit
345.4353.58251.04177.77103.6161.03
Operating Income
79.9696.4249.4736.1524.4511.26
Net Income
47.9160.428.721.53185.44
Earnings Per Share
4.196.133.142.361.980.60
EPS Growth
-95.12%33.05%19.34%230.59%-70.22%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingSep '25 Mar '25 Mar '24 Mar '23
Aesthetic Devices & Device Consumables
80.4785.47118.1392.36
Aesthetic Products
511.51530.36342.99235.49
Total
591.99615.83461.11327.85

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
14.355.5131.8922.6728.19
Total Debt
171.16227.38150.5758.7438.1938.84
Net Cash (Debt)
-156.85-171.88-147.57-56.85-15.53-10.65
Net Cash Growth
------
Net Cash Per Share
-13.72-17.44-16.14-6.23-1.71-1.17

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
--54.06-80.44-29.282.9943.07
Capital Expenditures
--0.84-0.52-2.64-1.88-0.1
Free Cash Flow
--54.9-80.96-31.911.1142.97
Free Cash Flow Growth
-----97.43%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
58.34%57.42%54.44%54.22%53.23%49.07%
Operating Margin
13.51%15.66%10.73%11.03%12.56%9.06%
Pretax Margin
10.85%13.12%8.43%9.46%12.59%6.14%
Profit Margin
8.09%9.81%6.22%6.57%9.25%4.38%
FCF Margin
--8.91%-17.56%-9.73%0.57%34.55%